Home   Categories   Grid

Subscribe Now

Cancer Research UK and Abcam announce custom antibody partnership

Cancer Research UK and Abcam announce custom antibody partnership

Cancer Research UK and Abcam announce custom antibody partnership

07 July 2020

The company will provide custom protein-based reagents to targets identified by CRUK-funded researchers.


Illumina unveils its Cambridge accelerator trio, with support from Combined Authority

Illumina unveils its Cambridge accelerator trio, with support from Combined Authority

Illumina unveils its Cambridge accelerator trio, with support from Combined Authority

29 June 2020

Alchemab Therapeutics, Neurolytic Healthcare and Tailor Bio will benefit from a package of support.


OKRA reaches two millions prediction for life science industry six months ahead of schedule

OKRA reaches two millions prediction for life science industry six months ahead of schedule

OKRA reaches two millions prediction for life science industry six months ahead of schedule

24 June 2020

The Cambridge AI company is working with top 10 pharma clients.


AI VIVO identified potential of Covid-19 treatment dexamethasone 10 weeks ago

AI VIVO identified potential of Covid-19 treatment dexamethasone 10 weeks ago

AI VIVO identified potential of Covid-19 treatment dexamethasone 10 weeks ago

23 June 2020

It says the steroid’s success is a validation of its AI-powered drug discovery engine.


Meri Williams ‘overjoyed’ at joining Healx as CTO to help find treatments for rare diseases

Meri Williams ‘overjoyed’ at joining Healx as CTO to help find treatments for rare diseases

Meri Williams ‘overjoyed’ at joining Healx as CTO to help find treatments for rare diseases

17 June 2020

She joins the Cambridge company from challenger bank Monzo to scale its technology and team.


Feedback raising £5.59m to scale Bleepa medical image viewing technology

Feedback raising £5.59m to scale Bleepa medical image viewing technology

Feedback raising £5.59m to scale Bleepa medical image viewing technology

17 June 2020

CEO Tom Oakley says it will help get the app out to clinicians across the UK and internationally.


Sareum raises £1m to advance preclinical studies and targets Covid-19 cytokine storm

Sareum raises £1m to advance preclinical studies and targets Covid-19 cytokine storm

Sareum raises £1m to advance preclinical studies and targets Covid-19 cytokine storm

10 June 2020

The Pampisford company says it has “compelling” data in models.


Avacta signs distribution deal for Covid-19 self-test under development

Avacta signs distribution deal for Covid-19 self-test under development

Avacta signs distribution deal for Covid-19 self-test under development

06 June 2020

It has signed an exclusive distribution deal with Medusa19.


NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

NodThera raises £44m to develop new class of medicines to fight inflammatory diseases

04 June 2020

Chesterford Research Park company’s strategy is described as ‘enormously promising’.


AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

AstraZeneca to begin supplying 100 million doses of Covid-19 vaccine to UK from September - if trials succeed

25 May 2020

CEO Pascal Soriot says he is ‘quite confident’ potential coronavirus vaccine will work - but admits it's a race to prove it.


Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

Health Enterprise East offers innovation grants up to £15,000 under MedTech NAVIGATOR programme

20 May 2020

The money will support SMEs looking to access expertise or test products.


Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

Bill Gates among investors as Cambridge Science Park-based Cerevance raises $45m to fight brain diseases

15 May 2020

The pharma company is carrying out groundbreaking work to fight Alzheimer’s.


Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

Prototype saliva test for Covid-19 ‘ready in weeks’ after Avacta ships Affimer reagents to Cytiva

15 May 2020

Its reagents bind to the SARS-CoV-2 viral antigen.


IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

IONTAS strikes deal with Paris biotech Inotrem to aid fight against inflammatory disease

14 May 2020

The Pampisford company will help identify suitable antibodies.


AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

AI VIVO seeks collaborators as 41 of its top-ranked potential Covid-19 drugs enter trials

13 May 2020

The Cambridge company says the trials are a validation of its approach.


Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

Two AstraZeneca molecules to be explored as Covid-19 treatments under government’s ACCORD platform

07 May 2020

The company has joined the platform, which is aimed at accelerating research and trials into potential therapies.


Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

Sanger Institute researchers help identify the nose cells that act as entry points for the Covid-19 virus

06 May 2020

The work reveals potential targets for tackling the high transmission of the coronavirus.


AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

AstraZeneca to work with University of Oxford on Covid-19 vaccine development and distribution

04 May 2020

They will adopt a non-profit approach during pandemic.


Coronavirus treatments: What we have learned so far about Covid-19

Coronavirus treatments: What we have learned so far about Covid-19

Coronavirus treatments: What we have learned so far about Covid-19

30 April 2020

Following our popular Q&A with Cambridge virologist Dr Jane Greatorex, she discusses what we have learned so far.


AstraZeneca launches trial to assess whether diabetes medicine can be repurposed for Covid-19 patients

AstraZeneca launches trial to assess whether diabetes medicine can be repurposed for Covid-19 patients

AstraZeneca launches trial to assess whether diabetes medicine can be repurposed for Covid-19 patients

29 April 2020

The DARE-19 trial will explore whether the drug dapagliflozin, sold as Farxiga, can reduce serious complications such as organ failure.

1

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More